Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 114.77% institutional investors, 2.16% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 17.22% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.21% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical114.77%2.16%-16.94%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.56M17.22%$159.17M
Eventide asset management2.64M8.18%$75.60M
Rubric capital management lp2.35M7.28%$67.33M
Vanguard group2.28M7.08%$65.40M
Pacer advisors2.14M6.64%$61.38M
Invesco1.78M5.50%$50.88M
Renaissance1.66M5.15%$47.60M
Principal financial group1.65M5.10%$47.13M
State street1.44M4.46%$41.17M
Fuller & thaler asset management1.35M4.19%$38.73M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Quantedge capital pte267.75K2.80%$7.67M
Eventide asset management2.64M1.38%$75.60M
Third avenue management203.40K1.13%$5.83M
Emerald mutual fund advisers trust569.57K0.99%$16.32M
Emerald advisers811.68K0.90%$23.25M
Rubric capital management lp2.35M0.86%$67.33M
Velan capital investment management lp28.68K0.71%$821.83K
Virtus investment advisers24.45K0.55%$700.38K
Tejara capital28.78K0.54%$824.58K
Summerhaven investment management23.91K0.42%$684.91K

Top Buyers

HolderShares% AssetsChange
Rubric capital management lp2.35M0.86%1.10M
Invesco1.78M0.01%289.33K
Janus henderson group291.39K0.00%221.90K
Ubs group200.52K0.00%164.30K
Qube research217.81K0.01%149.67K

Top Sellers

HolderShares% AssetsChange
Pacer advisors2.14M0.13%-447.16K
Goldman sachs group219.71K0.00%-355.53K
Federated hermes3.07K0.00%-327.43K
Arrowstreet capital, limited partnership---276.73K
Jpmorgan chase82.69K0.00%-194.51K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial84.88K0.00%84.88K$2.43M
F/m investments73.16K0.08%73.16K$2.10M
Knott david m jr32.93K0.34%32.93K$943.36K
Velan capital investment management lp28.68K0.71%28.68K$821.83K
Walleye capital24.51K0.00%24.51K$702.27K

Sold Out

HolderChange
Lindbrook capital-2.00
Mendota financial group-4.00
Capital performance advisors llp-22.00
Hollencrest capital management-25.00
True wealth design-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024239-5.16%37,025,520-3.74%1140.81%105-25.53%9322.37%
Sep 30, 20242528.15%38,464,415-2.96%1190.79%1418.46%76-
Jun 30, 20242330.43%39,636,436-0.49%1220.81%130-76-3.80%
Mar 31, 202423218.97%39,833,4831.57%1230.84%13042.86%792.60%
Dec 31, 202319511.43%39,219,2131.31%1210.92%91-7728.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.99M6.21%1.38K
Eventide Gilead N1.34M4.27%-
FullerThaler Behavioral Sm-Cp Eq R61.31M4.15%-
Eventide Healthcare & Life Sciences I1.29M4.08%-
FullerThaler Behavioral Small-Cap Equity1.31M4.06%-
Vanguard Total Stock Mkt Idx Inv979.17K3.11%-
Vanguard US Total Market Shares ETF993.93K3.09%-
iShares Russell 2000 ETF832.30K2.59%-7.21K
Principal SmallCap R5570.20K1.81%-7.60K
Principal U.S. Small Cap Equity581.90K1.80%-4.40K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 20, 2025Tupper Colleen EVP & Chief Financial OfficerSell$36.18K
Mar 21, 2025Tupper Colleen EVP & Chief Financial OfficerSell$192.07K
Mar 21, 2025Dreyer Scott EVP & Chief Commercial OfficerSell$566.98K
Mar 20, 2025Dreyer Scott EVP & Chief Commercial OfficerSell$57.81K
Mar 11, 2025Dreyer Scott EVP & Chief Commercial OfficerSell$461.67K

Insider Transactions Trends


DateBuySell
2025 Q1-14
2024 Q4--
2024 Q3-4
2024 Q2-6
2024 Q1-4

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 114.77%, followed by 2.16% insiders and -16.93% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.56M shares, 17.22%), Eventide asset management (2.64M shares, 8.18%), and Rubric capital management lp (2.35M shares, 7.28%). Together, they hold 32.69% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Quantedge capital pte is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.80% of its assets in 267.76K Collegium Pharmaceutical shares, valued at 7.67M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.21% of its total shares outstanding invested in 1.99M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools